Sukhani told CNBC-TV18, "Panacea Biotech is a stock in the Biotech area which is having a fair amount of glamour as of now, Panacea Biotech has now consolidated with very strong support around Rs 180."
He further added, "Stocks which consolidate in a bull market usually breakout on the upside and go much higher and I expect Panacea to do the same. I am buying this stock for a very modest intra-day target of Rs 195. Position traders and investors can hold it for much better gains."
Disclosure: I have no personal holding in the above stock.
